QPI-1002 Phase III
QPI-1007 Phase III
PF-655 Phase II
Check Pipeline

Quark Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that is a leader in the discovery and development of novel RNAi-based therapeutics.

We have a fully integrated Research and Development team with a proven track record of translating our innovations in RNAi therapeutics from the bench to the clinic. We have full capabilities in the areas of cell and molecular biology, protein biochemistry, monoclonal antibody technology, bioinformatics, animal pharmacology, histopathology including immunohistochemistry and in situ hybridization, and drug delivery. Our development teams, to-date have progressed three drug candidates through four INDs into clinical studies in five different disease indications.